...
首页> 外文期刊>Eye and Vision >Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery
【24h】

Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery

机译:黄斑类胡萝卜素补充改善了残障眩光表现和光应激恢复的动力学

获取原文
           

摘要

Background The so-called macular carotenoids (MC) lutein (L), zeaxanthin (Z), and meso-zeaxanthin (MZ) comprise the diet-derived macular pigment (MP). The purpose of this study was to determine effects of MC supplementation on the optical density of MP (MPOD), repeated-exposure photostress recovery (PSR), and disability glare (DG) thresholds. Methods This was a double-blind, placebo-controlled trial. Fifty-nine young (mean age?=?21.7), healthy volunteers participated in this study. Subjects supplemented their daily diet with either 10 mg L?+?2 mg total Z (1 mg Z?+?1 mg MZ; n =?24), 20 mg L?+?4 mg total Z (2 mg Z?+?2 mg MZ; n =?25), or placebo ( n =?10) for 12 months. The primary outcome was a composite measure of visual performance in glare, defined by change in DG and PSR. Secondary outcomes included MPOD and visual fatigue. The primary endpoint for outcomes was 12 months. MPOD was assessed with customized heterochromatic flicker photometry. PSR times for an 8 cycle /degree, 15 % contrast Gabor patch target were determined after each of five successive exposures to intense LED lights. DG threshold was defined as the intensity of a ring of lights through which subjects were able to maintain visibility of the aforementioned target. Measures of all parameters were conducted at baseline, 6 months, and 12 months. Repeated-measures ANOVA, and Pearson product-moment correlations were used to determine statistically significant correlations, and changes within and between groups. Results MPOD for subjects in both supplementation groups increased significantly versus placebo at both 6- and 12-month visits ( p
机译:背景技术所谓的黄斑类胡萝卜素(MC)叶黄素(L),玉米黄质(Z)和内消旋玉米黄质(MZ)包含饮食中的黄斑色素(MP)。这项研究的目的是确定补充MC对MP的光密度(MPOD),反复曝光的光应激恢复(PSR)和残障眩光(DG)阈值的影响。方法这是一项双盲,安慰剂对照试验。 59名健康志愿者(平均年龄21.7)。受试者在日常饮食中补充了10 mg L?+?2 mg总Z(1 mg Z?+?1 mg MZ; n =?24),20 mg L?+?4 mg总Z(2 mg Z?+ ≤2 mg MZ; n =≤25)或安慰剂(n =≤10)持续12个月。主要结果是眩光视觉性能的综合量度,由DG和PSR的变化定义。次要结果包括MPOD和视觉疲劳。结果的主要终点为12个月。 MPOD用定制的异色闪烁光度法评估。在连续5次强光照射后,确定8个循环/度,15%对比度的Gabor贴片目标的PSR时间。 DG阈值定义为一圈光的强度,受试者可以通过该光环保持上述目标的可见性。在基线,6个月和12个月时进行所有参数的测量。重复测量方差分析和皮尔逊乘积矩相关性用于确定统计学上显着的相关性以及组内和组间的变化。结果在6个月和12个月的随访中,两个补充组的受试者的MPOD均较安慰剂显着提高(所有p均<0.001)。此外,与安慰剂相比,在6个月和12个月就诊时,PSR时间和DG阈值较基线有显着改善(所有p均<0.001)。在基线时,MPOD与DG阈值(r =?0.444; p =?0.0021)和PSR时间(r =?-0.56; p <?0.001)都显着相关。作为MPOD的函数,与线性相反,重复曝光的PSR曲线变得更加渐近。在整个研究期间,受试者的DG阈值的变化与PSR时间的变化显着相关(r =?-0.534; p <?0.001)。结论MPOD的增加导致PSR时间和DG阈值的显着改善。重复曝光的PSR曲线的渐近形状表明,MPOD的增加在明亮的光照条件下产生更一致的稳态视觉性能。这种作用的机制可能涉及MP的光学过滤和生化(抗氧化剂)特性。试用注册ISRCTN试用注册号:ISRCTN54990825。该手稿中报告的数据代表注册试验的次要结果指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号